2018年度 Journal Club

Oncology

No.

日付

Title: Journal PMID.

担当者

まとめ

17 20th/Feb

Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study.

JTO 2018 30217492

児玉

児玉

16 16th/Jan

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.

NEJM2018 29658848

金澤

石井

15 9th Jan

 

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study 

BMJ2018 30355745

大越

児玉
 14 20th/Dec

Three new disease-progression modes in NSCLC patients after EGFR-TKI treatment by next-generation sequencing analysis.

 Lung Cancer2018 30429037

児玉

児玉
 13 20th/Nov

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.

NEJM 2018 30280641

井部

児玉
 12 7th/Nov

Novel therapies for malignant pleural mesothelioma

Lancet 2018 29508763 児玉
 11 24th/Oct

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and

Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer

JCO 2018 30125216 大越 石井
 10 10th/Oct 

Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events

 

J. Immunotherapy of Cancer 2018

29789020 坂木 石井
 9 3rd/Oct

Safety of Programmed Death-1 Pathway Inhibitors Among Patients With Non-Small-Cell Lung Cancer and Preexisting Autoimmune Disorders

 JCO 2018

29746230 皆川 児玉
 8 12th/July

Cancer immunotherapy efficacy and patients’ sex: a systematic review and meta-analysis

Lancet 2018

29778737 岡崎 児玉
 7 20th/June

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

NEJM 2018

29863955 児玉 児玉
 6 13th/June

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients

With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

JCO 2018

29746227 加世田 児玉
 5 23rd/May

Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion

NEJM 2018

29617585 森山 児玉
 4 16th/May

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

NEJM 2018

29658845 児玉
 3 25th/Apr

Predictive performance of the quick Sequential Organ Failure Assessment score as a screening

tool for sepsis, mortality, and intensive care unit admission in patients with febrile neutropenia

Suppoet Care Cancer

2018

28062972 坂木 児玉
 2 18th/Apr

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer

NEJM 2018

29658856 児玉 児玉
 1 4th/Apr

Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study

Lancet 2018

29249325 井部 児玉

COPD&Asthma

No.

日付

Title: Journal PMID.

担当者

まとめ

6 6th/Feb

 

Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial.

2017 JACI 28687232

濵元

児玉
 5 5th/Dec

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.

NEJM 2016 26949137

中村

児玉
 4 14th/Nov

Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.

Lancet Resp. 2018
30343028

井上

(研)

 
 3 30th/May Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

NEJM 2018  29668352 濵元 濵元
 2 6th/June Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations NEJM 2018  29504499 岡崎 児玉
 1 4th/July Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma NEJM 2018  29782217 加世田 濵元

Infection

No.

日付

Title: Journal PMID

担当者

まとめ

10 13rd/Feb

Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis

NEJM2019 30152252 井部 石井
9 30th/Jan

Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia.

JAMA 2019 30667477

増谷

石井
8 23rd/Jan

Proactive Use of High-Flow Nasal Cannula With Critically Ill Subjects.

Respi Care 29208754 坂木 児玉
7 26th/Dec

Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.

NEJM 2018 30184455 福田 石井
6 12th/Dec

 Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.

 NEJM 2018 30428290 森山 石井
5 17th/Oct Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults  NEJM 2018 30067931 福田 濵元
4  5th/Sep

A Randomized Trial of Itraconazole vs Prednisolone in Acute-Stage Allergic Bronchopulmonary

Aspergillosis Complicating Asthma

 Chest 2018 29331473 児玉 児玉
3 18th/July

Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection

 NEJM 2018 29781385 濵元 児玉
2 27th/June

Management of severe sepsis in patients admitted to Asian intensive care units:

prospective cohort study

 BMJ 2018 21669950 坂木 児玉
1 25th/April

Predictive performance of the quick Sequential Organ Failure Assessment score as a screening tool for sepsis, mortality, and intensive care unit admission in patients with febrile neutropenia

Support Care Cancer 2018 28062972 坂木 児玉

Allergy

No.

日付

Title: Journal PMID

担当者

まとめ